News

Internationally renowned for pioneering achievements and geared to inter-institutional cooperation: 22 research groups at the Berlin Institute for Medical Systems Biology in the Max Delbrück Center (MDC-BIMSB) explore how genes regulate life. It is now celebrating its 15th birthday.

The Max Delbrück Center in Berlin and Heidelberg University will found a new Helmholtz Institute for Translational AngioCardioScience (HI-TAC) in Mannheim and Heidelberg. The Helmholtz Senate voted in favor of the institute, which will integrate vascular biomedicine, systems biology and heart research.

Armaghan Naghipour, State Secretary for Science, Research and Equality, informed herself about the development of the Berlin-Buch Science and Biotech Campus on February 10, 2023.

Six sites are now collaborating with the Deutsches Krebsforschungszentrum (German Cancer Research Center) in the National Center for Tumor Diseases (NCT). In Berlin, a central partner is the Charité – Universitätsmedizin Berlin, in close cooperation with the Berlin Institute of Health at the Charité (BIH) and the Max Delbrück Center.

There’s likely to be a fundamental difference between how a medical practicioner and an artist view genetic editing with CRISPR. But both perspectives reveal possible ways to shape life in nature. Science meets art: the Max Delbrück Center at the Salon Sophie Charlotte 2022 in Berlin.

With a position paper developed under the umbrella of Berlin Research 50, the non-university institutions of Berlin emphasize what is important for science in Berlin. They state ten demands that should be implemented by the future senate to strengthen Berlin as science metropolis.

Boosting the immune system with kefir grains, developing smart road models and writing a program for chemical reactions: the winners of the 56th regional contest at Campus Berlin-Buch impressed the judges with their complete dedication and imaginative projects.

A year ago, BIH, MDC and Charité launched the joint research focus "Single Cell Approaches for Personalised Medicine". Its aim is to use innovative single cell technologies to answer clinical questions. This aspiration will be put into practice by four new junior research groups, which have now started.

Anton Henssen of the ECRC has been awarded the Kind Philipp Award for Pediatric Oncology Research for his study of ring-shaped DNA and its significance in the development of childhood neuroblastoma. A publication in the scientific journal Nature Genetics was decisive for this award.

The European Research Council (ERC) awarded Dr. Mina Gouti a €2.8 million Consolidator Grant to further develop miniature neuromuscular organoids for studying neuromuscular development and diseases. It was the second honor in as many weeks; she was also named an EMBO Young Investigator for her work.